U.S. Owns Patent Rights To Remdesivir, But Is Content To Let Gilead Jack Up Prices
"I think that we need more companies making it, so we have enough drug for the people who need it and so that the price can be driven down so that people can afford it," Dr. Rochelle Walensky said.
Gilead Charges $3,120 For Covid-19 Drug Developed With $70M In Taxpayer Money
"Absolute robbery," and the Mister "Art of the Deal" is doing nothing about it.
WATCH As Congressman Bawls In Emotional Defense Of Corporate Profits
Chip Roy (R-TX) became emotional when a giant pharmaceutical was questioned.
